HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Guest Access | Sign In via User Name/Password

This Article Full Text Free Full Text (PDF) Free Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Article Archive Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (20) Citing Articles via Google Scholar Google Scholar Articles by Cely, C. M. Articles by Schein, R. M. H. Search for Related Content PubMed PubMed Citation Articles by Cely, C. M. Articles by Schein, R. M. H.

Relationship of Baseline Glucose Homeostasis to Hyperglycemia During Medical Critical Illness^*

^* From the Division of Pulmonary and Critical Care Medicine (Drs. Cely, Quartin, Kett, and Schein), University of Miami, Miami, FL; and the Division of Nephrology (Dr. Arora), Columbia University and Harlem Hospital Center, New York, NY.

Correspondence to: Andrew Quartin, MD, MPH, Section of Critical Care Medicine (111), Miami VAMC, 1201 NW Sixteenth St, Miami, FL 33125; e-mail: aquartin{at}med.miami.edu

Study objective: To elucidate the relationship of baseline glucose control and acute stimuli with hyperglycemia during medical critical illness.

Design: Prospective cohort study.

Setting: Medical ICU (MICU) of a university affiliated hospital.

Patients: Convenience sample of 100 medical patients meeting criteria for severity of illness and anticipated length of stay and not admitted to the hospital for diabetic ketoacidosis or a hyperglycemic hyperosmolar state.

Interventions: None.

Measurements and main results: Patients were categorized as having normal, abnormal, or unevaluable baseline glucose control based on history and glycosylated hemoglobin (HbA1c). Data collection included blood glucose measurements within 120 h of MICU admission, and dosing of norepinephrine, corticosteroids, propofol, and carbohydrates. Average blood glucose and times over glycemic thresholds were calculated using linear interpolation. Hyperglycemia (glucose > 110 mg/dL) was pervasive in all groups. Among the 51 patients with normal baseline glucose control, HbA1c was correlated with hyperglycemic time (p < 0.01, R² = 0.15). Multiple regression found HbA1c, age, corticosteroid dose, and carbohydrate administration independently associated with hyperglycemic time (p < 0.05 for each, total R² = 0.49) in these patients, while body mass index, APACHE (acute physiology and chronic health evaluation) II, norepinephrine dose, propofol dose, gender, and sepsis were not associated with time > 110 mg/dL. Among normal subjects, HbA1c was independently predictive of peak and average glucose, and the fraction of time glucose was > 150 mg/dL and > 200 mg/dL (p < 0.05 for each). Patients with abnormal baseline glucose control had significantly more hyperglycemia than patients with normal baseline control.

Conclusions: Even in patients without evidence of abnormal glucose homeostasis at baseline, hyperglycemia is common during critical illness. Time exposure to hyperglycemia is correlated with acute stressors and baseline glucose regulation, as characterized by HbA1c. Patients with low HbA1c levels are less disposed to hyperglycemia during severe illness than patients with higher, but still normal, HbA1c.

Key Words: blood glucose • critical care • critical illness • diabetes mellitus • glycosylated hemoglobin A • hyperglycemia

This article has been cited by other articles:

				F. O. Kooij, J. E. Kal, P. C. Hans, and V. L. Bonhomme Blood glucose concentration profile after 10 mg dexamethasone in non-diabetic and type 2 diabetic patients. Br. J. Anaesth., December 1, 2006; 97(6): 896 - 897. [Full Text] [PDF]

				G. Van den Berghe, A. Wilmer, G. Hermans, W. Meersseman, P. J. Wouters, I. Milants, E. Van Wijngaerden, H. Bobbaers, and R. Bouillon Intensive Insulin Therapy in the Medical ICU N. Engl. J. Med., February 2, 2006; 354(5): 449 - 461. [Abstract] [Full Text] [PDF]

				A. X. Freire, L. Bridges, G. E. Umpierrez, D. Kuhl, and A. E. Kitabchi Admission Hyperglycemia and Other Risk Factors as Predictors of Hospital Mortality in a Medical ICU Population Chest, November 1, 2005; 128(5): 3109 - 3116. [Abstract] [Full Text] [PDF]

				J. J. M. Ligtenberg, S. Meijering, M. Vogelzang, M. W. N. Nijsten, I. C. C. van der Horst, J. E. Tulleken, and J. G. Zijlstra Relationship of Baseline Glucose and Mortality During Medical Critical Illness? Chest, June 1, 2005; 127(6): 2283 - 2283. [Full Text] [PDF]